GNLK.OB: Summary for GENELINK INC - Yahoo! Canada Finance

MORE ON GNLK.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

GENELINK INC (OTC BB:GNLK.OB) Delayed quote data

Last Trade:	0.16 USD
Trade Time:	Nov 23
Change:	0.00 (0.00%)
Prev Close:	0.16
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	0.06 - 0.56
Volume:	0
Avg Vol (3m):	576,280
Market Cap:	17.71M
P/E (ttm):	N/A
EPS (ttm):	-0.03
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add GNLK.OB to Portfolio

Download Data

HEADLINES

•	GENELINK INC Financials
	EDGAR Online Financials (Thu, Nov 19)

•	GeneLink Reports Third Quarter Results
	Business Wire (Mon, Nov 16)

•	GENELINK INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 13)

•	GENELINK INC Files SEC form 10-K/A, Annual Report
	EDGAR Online (Thu, Nov 5)

•	GeneLink BioSciences, Inc. Ranked Number 92 Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500TM
	Business Wire (Wed, Oct 21)

•	GeneLink BioSciences, Inc. Names Doug Boyle to Board of Directors
	Business Wire (Mon, Oct 5)

•	GENELINK INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Mon, Oct 5)

•	GeneWize Life Sciences, Inc., Approved As New Member of Direct Selling Association
	Business Wire (Thu, Sep 24)

•	GENELINK INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Wed, Aug 19)

•	GENELINK INC Files SEC form 8-K, Other Events
	EDGAR Online (Thu, Aug 13)

More Headlines for GNLK.OB...

BUSINESS SUMMARY

GeneLink, Inc., together with its subsidiary, Dermagenetics, Inc., operates as a biosciences company that creates genetic tests as the basis for personalized health, beauty, and wellness applications.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

GeneLink Inc. (GNLK.OB)